טוען...
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody
Therapy of melanoma using T-cells with genetically introduced T-cell receptors (TCRs) directed against a tumor-selective cancer testis antigen (CTA) NY-ESO1 demonstrated clear antitumor responses in patients without side effects. Here, we exploited the concept of TCR-mediated targeting through intro...
שמור ב:
| הוצא לאור ב: | Int J Nanomedicine |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4792179/ https://ncbi.nlm.nih.gov/pubmed/27022262 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S96123 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|